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Abstract 
In human peripheral blood lymphocytes stimulated via the T-cell antigen receptor/CD3 complex IL-2 synthesis and cellular 
proliferation were effectively inhibited by a concentration of ouabain as low as 50 nM, whilst the expression of high affinity IL-2 
receptors was not influenced. Binding of the monoclonal antibody, BMA 031 to the T-cell antigen receptor/CD3 complex resulted in a 
bimodal activation of protein kinase C. The activation of protein kinase C-(Y in the early phase of T-lymphocyte activation was not 
affected by 50 nM ouabain, in contrast sustained activation of protein kinase C-/3, between 90-240 min of stimulation was completely 
abolished by the cardiac glycoside. When protein kinase C was directly activated by PMA + ionomycin, 50 nM ouabain was ineffective 
in inhibiting protein kinase C activation, as well as subsequent IL-2 synthesis, suggesting that the glycoside interfered with signal 
transducing mechanism(s) upstream of the activation of protein kinase C. Ouabain had no influence on the elevation of intracellular 
calcium concentration in BMA 031 stimulated lymphocytes, ruling out the possibility that it interfered with the T-cell antigen receptor 
dependent phosphatidylinositol response. In contrast, lysophosphatide acyltransferase catalysed elevated incorporation of polyunsaturated 
fatty acids was effectively inhibited by low concentrations of ouabain in BMA 031-stimulated T-lymphocytes, whereas stimulation with 
PMA + ionomycin had no influence on the plasma membrane phospholipid fatty acid metabolism. These results suggest, that differential 
signal transduction pathways are involved in the activation of protein kinases C-a and -/3. They implicate that elevated incorporation of 
polyunsaturated fatty acids into plasma membrane phospholipids might contribute to sustained activation of protein kinase C-/3, and 
establish a link between activation of protein kinase C-p and induction of IL-2 synthesis in human lymphocytes. 
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1. Introduction 
The antigen or mitogen induced proliferation of resting 
T lymphocytes involves at least two major events; the 
synthesis and secretion of the ultimate mitogen interleukin 
2 (IL-2) and the synthesis and surface expression of recep- 
tors thereof. Both events are initiated by the binding of 
activating ligands to the T-cell receptor/CD3 complex [l]. 
Abbreviations: CHAPS, 3-((3-cholaminopropyl)dimethylammonio)- 
1-propanesulfonate; DMSO, dimethylsulfoxide; DTE, dithioerythritol; 
Hepes, (2-hydroxyethyl)piperazine-N’-(2-ethanesulfonic acid); TCA, tri- 
chloroacetic acid, PMA, phorbol 12-myristate ll-acetate; Tricine, N- 
tris(hydroxymethyl)methylglycine; Tris, tris(hydroxymethyl)amino- 
methane. 
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As an immediate consequence of the ligand T-cell receptor 
interaction the activation of phospholipase C catalysed 
hydrolysis of phosphatidylinositol-4,Sbisphosphate (PIP,), 
the so-called ‘PI response’, has been well established. 
Generation of the cleaving product inositol 1,4,5triphos- 
phate (IP,) is linked to an elevation of the cytosolic free 
calcium concentration. Besides an increase in cytosolic 
calcium concentration formation of diacylglycerol second 
messengers within the plasma membrane have also been 
shown in response to antigen or mitogen stimulation [l]. 
Diacylglycerol second messengers activate protein kinases 
C, a family of enzymes responsible for many cellular 
functions and growth regulation [2]. 
Recently it has been shown that short-lived diacylglyc- 
erols led to short and transient activation and translocation 
of protein kinase C. While this was sufficient for the 
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expression of functionally active IL-2 receptors, synthesis 
of IL-2 required a sustained activation of the enzyme. 
These data implicated that an additional molecular mecha- 
nism coupled to the T-cell antigen receptor complex is 
involved in the cellular signalling leading to IL-2 gene 
expression and subsequent proliferation of T-lymphocytes 
[3-51. 
Recently we have shown that in lymphocytes which 
received a single dose of short lived diacylglycerol incor- 
poration of polyunsaturated fatty acids into plasma mem- 
brane phospholipids prolonged protein kinase C activation, 
which subsequently led to IL-2 synthesis and proliferation 
of human lymphocytes. Furthermore, we have shown that 
monoclonal antibodies raised against the T-cell antigen 
receptor/CD3 complex caused a bimodal activation of 
protein kinase C. These data suggested that long-term 
activation of protein kinase C, most probably involving 
elevated incorporation of &-polyunsaturated fatty acids 
into plasma membrane phospholipids, was an absolute 
requirement of IL-2 synthesis in human lymphocytes [6]. 
Here we report that in human lymphocytes stimulated via 
the T-cell antigen receptor/CD3 complex the initial short 
term activation of protein kinase C is due to the protein 
kinase C isoenzyme, PKC-(Y, whereas the sustained activa- 
tion is related to activation of protein kinase C-p. Inhibi- 
tion by ouabain of the incorporation of polyunsaturated 
fatty acids into plasma membrane phospholipids abolishes 
the long-lasting activation phase of protein kinase C-p and 
the subsequent synthesis of IL-2 in human peripheral 
blood lymphocytes. 
2. Materials and methods 
2.1. Materials 
Mouse mAb BMA 031 (IgG,,), raised against 
monomorphic determinants of the T-cell antigen receptor 
was a kind gift of Behringwerke AG, Marburg. Ionomycin 
(Calbiochem) and phorbol 12-myristate 13-acetate (PMA) 
(Sigma) were dissolved as a stock solution in DMSO at a 
concentration of 5 mg/ml. For activation of cells aliquots 
were diluted with RPM1 1640 medium. Fatty acids, i.e., 
linoleic acid (l&2), linolenic acid (l&3) and arachidonic 
acid (20:4) (NuCheck Corp.) were dissolved at a concen- 
tration of 1 mg/ml in chloroform:methanol (2:l v/v) and 
stored at - 20” C. Before use aliquots were evaporated 
under N, and suspended in RPM1 medium containing 5 
mg/ml defatted albumin by sonification (50 w, three times 
10 s at 4” C). Human recombinant interleukin-2 (hr-IL-2) 
and ouabain were from Boehringer, Mannheim. 
2.2. Cells and cell culture 
Peripheral blood lymphocytes were isolated by 
Ficoll/Isopaque gradient centrifugation. Cells were washed 
with RPM1 1640 and cultured in RPM1 1640 supplemented 
with 10% defatted FCS, 100 U penicillin, 100 pg/ml 
streptomycin and 2 mM glutamine in flat bottom microtiter 
plates at a density of 4 . lo5 cells/well. Lymphocytes 
were activated by BMA 031 (5 pg/ml), PMA (100 ng/ml) 
and ionomycin (0.5 pg/ml) or their combinations as 
indicated in the experiments. These concentrations proved 
to be optimal in inducing lymphocyte proliferation [4,5]. 
After incubating cells for 68 h 0.5 PCi of 
[3H]thymidine/well (20 Ci/mmol, Amersham) was added 
for a further 4 h. Cells were then harvested with an 
automatic cell harvester and [ 3H]thymidine incorporation 
determined by liquid scintillation counting. 
2.3. Determination of IL-2 synthesis 
Cells (2 . lo5 in 0.2 ml of RPM1 medium) were stimu- 
lated with the monoclonal antibody BMA 031 or with a 
combination of PMA + ionomycin, as indicated in the 
experiments, in flat bottom microtiter plates for 20 h. The 
supernatants were harvested and IL-2 activity quantitated 
with the help of the murine IL-2 dependent CTLL line as 
described by Gillis et al. [7]. Control experiments showed 
that neither DMSO nor any of the substances (i.e., PMA, 
ionomycin, ouabain) influenced growth and proliferation 
of the CTLL line, thus showing that proliferation of the 
CTLL line was really due to the presence of different 
amounts of IL-2. 
2.4. Isolation and identification of IL-2 specific mRNA 
Human lymphocytes were stimulated for 20 h in 250 ml 
Costar flasks (vol, 50 ml), at a cell density of 2 . 106/ml 
with 5 pg/ml of BMA 031 or with 100 ng/ml PMA + 0.5 
pg/ml ionomycin, respectively. Subsequently RNA was 
isolated as described in Ref. [4]. Briefly, total cellular 
RNA was prepared by the guanidine isothiocyanate method, 
size-fractioned on formaldehyde-agarose gels and trans- 
ferred to nitrocellulose filters. For hybridization, cDNA 
probes were nick translated with [32P]dCTP (3000 
Ci/mmol) to specific activities of (2-5). lo8 cpm/pg. 
Hybridization was carried out as described in [B]. 
2.5. Binding of IL-2 
Binding of IL-2 was carried out as described earlier [4]. 
Briefly, human lymphocytes were stimulated for 24 h. 
Cells were then washed and 5 . lo6 lymphocytes were 
incubated in 0.2 ~1 with 0.1 &i ‘251-IL-2 (spec. act. 900 
Ci/mmol) and different concentrations of IL-2 ranging 
from 0.2 pmol to 200 nmol at 4” C for 1 h. Free and bound 
radioactivity were separated by centrifugation through sili- 
con oil as described 141. Number and affinity of the 
receptors were calculated by Scatchard analysis with a 
computer program. 
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2.6. Determination of intrtzcellular calcium 
Human lymphocytes were preincubated with ouabain 
for 4 h then loaded in the dark with 1 PM fura-2AM in 
medium HBSS (Hanks’ balanced salt solution). Cells were 
then washed and allowed to recover for 30 min at 3” C in 
medium RPMI/lO% fetal calf serum. Immediately before 
use aliquots containing 5 . lo6 cells were washed, resus- 
pended in HBSS and stimulated with 5 pg/ml BMA 031. 
Elevation of intracellular free calcium was detected in a 
fluorescence photometer with dual excitation at 340 and 
380 nm. Emission was monitored at 505 nm. Cells were 
lysed with 1% Triton X-l00 to determine ratios at maxi- 
mum calcium concentrations, then calcium was chelated 
with 10 mM EGTA (pH 8.3) to determine ratios at mini- 
mum calcium concentrations. Fluorescence intensity ratios 
were converted into calcium concentrations using a com- 
puter program. 
2.7. Incorporation of fatty acids into phospholipids 
Lymphocytes (5 . lo6 cells) were incubated in 1 ml 
RPM1 1640 supplemented with 1 mg/ml defatted bovine 
serum albumin with 10 nmol of [‘4C]linoleate, [‘4C]lino- 
lenate or [‘4C]arachidonate, respectively, by mixing 14C- 
labelled fatty acids (Amersham) and unlabelled fatty acids 
(NuCheck). The specific activity was kept constant at 5 
mCi/mmol. 
2.8. Extraction and analysis of lipids 
Lipids were extracted as described earlier [9] and sepa- 
rated by thin layer chromatography on TLC plastic sheets 
(Silica gel 60, layer thickness 0.2 mm) with a mixture of 
chloroform/methanol/acetic acid/0.9% NaCl (v/v, 
50:25:8:4) at 4” C. The individual lipid fractions were 
visualized by iodine vapor, cut off and counted by liquid 
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Fig. 1. Inhibition by ouabain of thymidine incorporation in BMA 031 and in PMA + ionomycin stimulated human lymphocytes. Human peripheral blood 
lymphocytes (2 lo6 cells/ml) were preincubated with ouabain for 4 h. Cells were then washed and stimulated with BMA 031 (5 pg/ml) or with PMA 
(100 ng/ml) and ionomycin (0.5 pg/ml), respectively, in the presence or absence of hr-IL-2 (100 U/ml). After 68 h of incubation [3H]thymidine was 
added for further 4 h and incorporation into DNA measured as described under Materials and methods. Results are means + S.D. or triplicates of three 
independent experiments. O-O, control, O-0, BMA 031, B-B, PMA + ionomycin. (Inset) Inhibition by ouabain of IL-2 gene expression of 
human peripheral blood lymphocytes. Human peripheral blood lymphocytes (10’ cells) were preincubated with ouabain (50 nM) for 4 h. Cells were then 
washed and activated with 5 w.g/ml BMA 031 or with 100 ng/ml PMA + ionomycin (0.5 pg/ml) for 8 h. Total cellular RNA was then extracted and 
size-fractionated as described under Materials and methods. Hybridization and autoradiography were performed as described under Materials and methods. 
1, Control; 2, BMA 031; 3, BhfA 031 + ouabain; 4, PMA + ionomycin; 5, PMA + ionomycin + ouabain. 
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scintillation counting. Incorporation was measured in frac- 
tions containing phosphatidylcholine, phosphatidylinositol, 
phosphatidylserine and phosphatidylethanolamine. 
2.9. Isolation of subcellular fractions porn human lympho- 
cytes 
Lymphocytes (5 . lo6 cells/ml) were preincubated with 
5 . lo-* M ouabain for 4 h and stimulated with BMA 031 
(5 pg/ml) or PMA (100 ng/ml) for different lengths of 
time as indicated in the experiments. Cells were then 
washed and resuspended in isolation buffer (20 mM Hepes 
(pH 7.4), 1 mM EGTA, 1 mM EDTA, 5 mM DTE and 50 
pg/ml leupeptin) at a cell density of lo8 cells/ml. Cells 
were disrupted by nitrogen cavitation and cytosolic and 
plasma membrane fractions isolated as described earlier 
[4,6,10]. As lymphocytes contain a relatively small amount 
of endoplasmic reticulum, our preparation can be consid- 
ered as a crude plasma membrane fraction containing less 
than 10% contamination by endoplasmic reticulum [lo]. 
Protein was determined as described in [lo]. 
2.10. Protein kinase C assay 
Protein kinase C activity was determined as described 
elsewhere [4,6,10]. Briefly, samples were processed for 
determination of protein kinase C activity immediately 
after isolation. Cytosolic protein kinase C was measured in 
aliquots of the cytosolic fraction without further purifica- 
tion. Plasma membrane bound protein kinase C was solubi- 
lized by 1 mM CHAPS (3-((3-chloramidopropyl)dimethyl- 
ammonia)-1-propanesulfonate) in isolation buffer for 20 
min at 4” C setting the protein concentration to 1 mg/ml. 
The nonsolubilized material was removed by centrifuga- 
tion (100000 X g, 60 min, 4” C). Protein kinase C was 
Table 1 
Inhibition by ouabain of IL-2 secretion in stimulated lymphocytes 
Stimulus Ouabain IL-2 secreted 
(nmol/I) (U/ml) 
- - n.d. 
1000 n.d. 
BMA 031 _ 30+ 2 
1 32+ 2 
5 16+ 1 
10 7* 3 
50 <2 
PMA + ionomycin - 212+ 10 
10 203 + 12 
50 196+20 
100 185k 8 
500 108+ 4 
1000 10* 2 
Lymphocytes were preincubated with ouabain for 4 h. Cells were then 
washed and stimulated for 20 h, IL-2 secretion was determined as 
described in Materials and methods. 
nd.: not detectable. 
measured in a reaction mixture containing 40 mM Hepes, 
10 mM MgCl,, 0.4 mM EGTA, 400 /*g/ml histone (type 
III, Sigma) and 60 /.LM [ 32 P]ATP (100 cpm/pmol) with or 
without 2 mM CaCl,, 200 pg/ml phosphatidylserine and 
20 pg/ml 1,2-diolein. Lipids were dispersed by sonifica- 
tion. The reaction was started by mixing 100 ~1 of reac- 
tion medium with 10 pg of sample protein in isolation 
buffer. After an incubation for 3 min at 37” C the reaction 
was stopped by the addition of 200 ~1 TCA (lo%, w/v) 
containing 15 mM K,HPO,. Precipitated protein was col- 
lected on 0.45 pm nitrocellulose filter. The precipitate was 
washed by 5 X 5 ml of cold TCA (5%, w/v> containing 15 
mM K,HPO,, the filters were dried and radioactivity was 
measured by liquid scintillation counting. The enzyme 
activity is expressed as the difference between the values 
measured in the presence and absence of phospholipids 
and calcium in nmol of 3zP transferred per min/mg pro- 
tein of the sample. 
2.11. Detection of protein kinase C isotypes by SDS-poly- 
acrylamide gelelectrophoresis and immunoblotting 
40 pug membrane protein was processed by SDS-PAGE 
on 10% polyacrylamide gels as described in [ill. Elec- 
troblotting of proteins to ImmobilonR membranes was 
carried out at a constant current of 200 mA for 2 h. Blots 
were then incubated with monoclonal antibodies against 
protein kinase C-cu, protein kinase C-p (Seikagaku Kogyo, 
Tokyo), respectively, for 4 h, followed by incubation with 
a biotin-streptavidin-alkaline-phosphatase-coupled second 
antibody. Nitroblue-tetrazolium (NBT) and 5-bromo-4- 
chloro-3-indolylphosphate (BCIP) (Amersham) were used 
as substrates to visualize protein kinase C subspecies. 
3. Results 
3.1. Inhibition by ouabain of [3H]thymidine incorporation 
in stimulated human peripheral blood lymphocytes 
As shown in Fig. 1 human lymphocytes showed a 
strong proliferative response to the monoclonal antibody, 
BMA 031, raised against the T-cell antigen receptor, as 
measured by [ 3 Hlthymidine incorporation. Similarly, a 
combination of PMA and ionomycin also induced cell 
proliferation, that could not be further enhanced by the 
addition of exogeneous hr-IL-2. i3H]Thymidine incorpora- 
tion was inhibited by ouabain in a concentration dependent 
way. Whereas in lymphocytes which were activated with 
BMA 031 thymidine incorporation was completely abol- 
ished by 50 nM ouabain, DNA synthesis of cells activated 
with PMA + ionomycin was relatively insensitive to 
ouabain treatment, and complete inhibition of stimulated 
thymidine incorporation was achieved only by 1 /IM 
ouabain. In lymphocytes which were activated by BMA 
031 inhibition of thymidine incorporation caused by 50 
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Table 2 
Lack of effect of ouabain on the induction of high affinity IL-2 receptors 
in BMA 031-stimulated human lymphocytes 
Stimulus Ouabain K, (x10-” M) Sites/cell 
_ - - < 50 
BMA 031 - 4.15 1430 
BMA 031 50 nM 4.11 1340 
BMA 031 1pM - n.d. 
PMA + ionomycin - 4.72 1390 
PMA + ionomycin 50 nM 4.51 1700 
1kM - n.d. 
Lymphocytes (2. lo6 cells/ml) were preincubated with ouabain for 4 h. 
Cells were then washed and stimulated with BMA 031 (5 pg/ml) or with 
PMA (100 ng/ml) and ionomycin (0.5 pg/ml) for 24 h. Cells were then 
washed again and 1251-IL-2 binding carried out as described under 
Materials and methods. Results are means of triplicates. 
n.d.: not detectable. 
ionomycin, resulted in high amounts of newly synthesized 
IL-2 (Table 1). In contrast, no IL-2 synthesis was measur- 
able in cells which were preincubated with 50 nM ouabain 
before activating them with BMA 031. At this concentra- 
tion ouabain had no effect on IL-2 synthesis in lympho- 
cytes stimulated by PMA + ionomycin. Only when ouabain 
concentration was raised to 1 PM synthesis of this lym- 
phokine was also suppressed in lymphocytes which were 
activated with PMA + ionomycin. 
3.3. Effect of ouabain in the expression of high affinity 
IL-2 receptors in BMA 031 and PM4 + ionomycin- 
stimulated human lymphocytes 
nM ouabain was fully reversible by the addition of exoge- 
neous hr-IL-2. In contrast, even very high concentrations 
of hr-IL-2 were unable to overcome the inhibition of DNA 
synthesis caused by 1 ILM ouabain, the concentration 
required for complete inhibition of activation by PMA and 
ionomycin. 
As shown in Table 2, neither the number nor the 
affinity of high affinity IL-2 receptors was altered by 50 
nM ouabain in BMA 031 or PMA + ionomycin stimulated 
cells. In contrast, no high affinity IL-2 receptors were 
detectable in stimulated cells in the presence of 1 PM 
ouabain. 
3.4. Ouabain prevents sustained activation of protein ki- 
nase C in B&I 031 -stimulated human lymphocytes 
As shown in the inset of Fig. 1 IL-2 gene expression 
was inhibited by 50 nM ouabain in BMA 031-stimulated 
lymphocytes, whilst this concentration of the glycoside 
was completely ineffective in inhibiting IL-2 gene expres- 
sion in cells activated with PMA + ionomycin. 
3.2. Effect of ouabain on the IL-2 synthesis in stimulated 
lymphocytes 
Stimulation of human lymphocytes with the monoclonal 
antibody (BMA 031), or with a combination of PMA and 
Activation of lymphocytes by BMA 031, PMA or PMA 
+ ionomycin, respectively, led to activation of protein 
kinase C (Fig. 2 and Table 3) as measured by its transloca- 
tion to the plasma membrane. PMA alone or in combina- 
tion with ionomycin induced a rapid long-lasting activation 
and translocation of protein kinase C; after 240 min 90% 
of the total enzyme activity was still associated with the 
plasma membrane (Table 3). Preincubation of the cells 
with ouabain (up to 1 PM) for up to 4 h did not affect the 
activation and translocation of protein kinase C in PMA 
Table 3 
Lack of effect of ouabain on the activation and translocation of protein kinase C to plasma membranes of human lymphocytes 
Stimulation (mitt) Ouabain Protein kinase C activity (nmol/mg protein per min) 
activator 
PMA PMA + ionomycin 
0 
0 
0 
10 
10 
10 
15 
15 
15 
120 
120 
120 
240 
240 
240 
_ 
50 nM 
1 FM 
_ 
50 nM 
IN 
50 nM 
~CLM 
_ 
50 nM 
ll*M 
- 
50 nM 
1 CLM 
245 f 12 218 f 10 
233 + 22 207+19 
255 + 39 226 f 34 
572 f 43 509 f 38 
559 + 25 497 + 22 
543 f 32 483 + 28 
649 f 34 577 * 30 
636 f 51 566 + 45 
600 f 44 534 + 24 
602 + 46 535 + 41 
613 f 37 545 + 32 
603 + 27 536 + 24 
578 * 31 514 f 27 
592 f 25 526 + 22 
584 f 38 519 + 33 
Human lymphocytes were preincubated with ouabain for 4 h. Cells were then washed and stimulated with PMA (100 ng/ml) or with the combination of 
PMA + ionomycin (0.5 I*.g/ml:l, respectively, for different lengths of time. Cells were then disrupted, plasma membranes isolated and protein kinase C 
activity determined as described under Materials and methods. Results are means f S.D. of triplicates of four independent experiments. 
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and/or PMA + ionomycin stimulated cells (Table 3). On 
the other hand, the monoclonal antibody BMA 031 re- 
sulted in activation and translocation of protein kinase C to 
the plasma membrane after 15 min of stimulation, then the 
specific activity declined to control levels after 30-60 min. 
This was followed by a second, long-lasting rise in the 
enzyme activity (up to 4 h) (Fig. 2A). When lymphocytes 
were preincubated with 50 nM ouabain before the addition 
of BMA 031, the initial activation of protein kinase C was 
still present, the second, long-lasting activation of the 
enzyme, however, was completely abolished (Fig. 2A). As 
shown in Fig. 2B cytosolic protein kinase C activity 
always behaved in a mirror-like fashion. 
3.5. Ouabain prevents the translocation of protein kinase 
C-p to the plasma membrane of BMA 031-stimulated 
human lymphocytes 
The results so far suggested that ouabain might influ- 
ence different signal transduction pathways leading to 
activation and translocation of different protein kinase C 
Plasma membrane 
- BMA 03l 
- BMA 03l+ ouabain 
LI 
OO 
I I I I I 
60 
&Z) - 
l&l 240 
Cytosol 
-MAO31 
- BMA 031+ auabain 
I I 
OO 
I I I I I 
60 120 180 240 
(min) - 
Fig. 2. Inhibition by ouabain of the sustained activation of protein kinase 
C in human lymphocytes. Peripheral blood lymphocytes were preincu- 
bated with 50 nM ouabain for 4 h. Cells were then washed and stimulated 
with BMA 031 for different lengths of time, as indicated on the abscissa. 
Cells were then homogenized, cytosolic and plasma membrane fractions 
prepared as described under Materials and methods. Protein kinase C 
activity was determined in plasma membrane (upper panel) and cytosolic 
fractions (lower panel) as described in Materials and methods. Results are 
means + SD. of triplicates of four independent experiments. 
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-I- OlJABAlN 
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0 1 5 103090120240min 
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Fig. 3. Inhibition by ouabain of translocation of protein kinase C-p to 
plasma membranes of human peripheral blood lymphocytes. Human 
lymphocytes (2. lo6 cells/ml) were preincubated with 50 nM ouabain for 
4 h. Cells were then washed and stimulated with BMA 031 for the times 
indicated. Cells were then taken up in isolation buffer and subcellular 
fractions isolated as described under Materials and methods. 40 pg 
plasma membrane protein was solubilized with CHAPS and processed to 
SDS-polyacrylamide gelelectrophoresis. Proteins were then transferred to 
ImmobilonR membranes (200 mA 2 h) and stained with monoclonal 
antibodies against protein kinase C-o and -p, respectively. Staining was 
carried out as described under Materials and methods. A single experi- 
ment out of four similar ones is shown. 
isotypes in lymphocytes stimulated via the T-cell antigen 
receptor/CD3 complex. 
In BMA 031-stimulated lymphocytes protein kinase 
C-(Y protein was translocated to the plasma membrane 
within 5 min, after 30 min of stimulation the amount of 
this isoenzyme reverted to control levels in the plasma 
membranes. Preincubation with 50 nM ouabain did not 
influence the translocation of protein kinase C-o (Fig. 
3A). In contrast translocation of protein kinase C-p pro- 
tein detectable between 90 min and 4 h in the plasma 
membrane of BMA 031-stimulated lymphocytes was com- 
pletely suppressed by pretreatment of cells with 50 nM 
ouabain (Fig. 3B). 
As the activation of the protein kinase C isoenzymes 
may independently be linked to the T-cell antigen receptor, 
it was an obvious possibility to investigate the effects of 
ouabain on different signalling processes in stimulated 
lymphocytes. 
3.6. Lack of effect of ouabain on the elevation of intra- 
cellular calcium concentration in BMA 031 -stimulated hu- 
man lymphocytes 
Fig. 4 shows that binding of the monoclonal antibody 
BMA 031 to the T-cell antigen receptor resulted in eleva- 
tion of intracellular calcium concentration within 1 min. 
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Fig. 4. Lack of effect of ouabain on the elevation intracellular calcium 
concentration in BMA 031-stimulated human lymphocytes. Peripheral 
blood lymphocytes were incubated with 50 nM ouabain for 4 h and 
loaded thereafter with Fura- as described in Materials and methods. 
Cells were stimulated with BMA 031 (5 pg/ml) (first arrow). F,,,,, and 
F,,,i, were determined by the addition of 1% Triton X-100 (second arrow) 
and 10 mM EGTA (third arrow), respectively. One representative experi- 
ment out of three similar independent ones is shown. 
Pretreatment of lymphocytes for 4 h with 50 nM ouabain 
did not exert any effect on the receptor-mediated elevation 
of intracellular calcium concentration. 
3.7. Ouabain inhibits the i,rzcorporation of polyunsaturated 
fatt>t acids into plasma membrane phospholipids of BMA 
031 -stimulated human lymphocytes 
When lymphocytes were activated with the monoclonal 
antibody BMA 031, the incorporation of different cis- 
polyunsaturated fatty acids, linoleic acid (18:2), linolenic 
acid (18:3), or arachidonic acid (20:4) into different phos- 
pholipid species was stimulated two to three fold (Fig. 5). 
Upon addition of ouabain the elevated incorporation of the 
fatty acids into plasma membrane phospholipids was inhib- 
ited in a concentration-dependent way, as shown earlier in 
mitogen stimulated human lymphocytes [12]. Complete 
inhibition of BMA 031-stimulated fatty acid incorporation 
was achieved by 50 nM ouabain. In sharp contrast, neither 
PMA alone, nor the combination of PMA and ionomycin, 
were able to stimulate the incorporation of saturated or 
polyunsaturated fatty acids into plasma membrane 
phospholipids (data not shown). Ouabain (up to 1 PM) 
had no effect on the incorporation of fatty acids in PMA + 
ionomycin stimulated cells or into resting cells. 
4. Discussion 
The induction of proliferation in resting T-lymphocytes 
requires at least two essential events; the synthesis and 
secretion of the ultimate mitogen interleukin-2 and the 
synthesis and surface expression of receptors thereof [l]. 
Ouabain, a known inhibitor of lymphocyte activation, at 
concentrations not affecting intracellular ion concentra- 
tions, has been shown in several species to selectively 
interfere with IL-2 synthesis [12-141. 
This was corroborated with human peripheral blood 
lymphocytes stimulated with the monoclonal antibody 
BMA 031, raised against the monomorphic determinants 
of the CY/@ chains of the T-cell antigen receptor. As 
human being represents the most ouabain sensitive species, 
a concentration as low as 50 nM completely suppressed 
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Fig. 5. Inhibition by ouabain of the BMA 031-stimulated incorporation of 
c&polyunsaturated fatty acids into phospholipids of human lymphocytes. 
Peripheral blood lymphocytes (5. lo6 cells/ml) were preincubated with 
ouabain for 4 h. Cells were then washed and stimulated with BMA 031 in 
the presence of “C-1abelled polyunsaturated fatty acids for 4 h. Lipids 
were then extracted and separated by thin-layer chromatography as 
described under Materials and methods. Results are means+S.D. of 
duplicates of three independent experiments. (A) Phosphatidylcholine, 
(B) phosphatidylinositol, (C) phosphatidylethanolamine, O-O, control; 
O-a, BMA 031+ linoleic acid (l&2); ??-H , BMA 031+ linolenic 
acid (l&3); A - A, BMA 031+ arachidonic acid (20:4). 
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BMA 031 induced proliferation, and completely blocked 
IL-2 synthesis (see Fig. 1 and Table l), while it had no 
effect on the expression of high affinity receptors (see 
Table 2), which represent the functionally active receptor 
in T-lymphocytes. Proliferation and IL-2 synthesis evoked 
by the phorbol ester (PMA) in combination with the 
calcium ionophore, ionomycin, proved to be resistant to 50 
nM ouabain. Only much higher concentrations of ouabain 
(i.e., 1 PM) led to inhibition of proliferation. At this high 
concentration ouabain prevented both IL-2 and IL-2 recep- 
tor synthesis also in PMA + ionomycin-stimulated cells. 
Ouabain at a concentration of 1 /IM leads to drastic 
changes of ion fluxes in human cells, thus those concentra- 
tions also directly interfere with protein synthesis [15] and 
hence are non-specific. 
For both events - IL-2 synthesis and IL-2 receptor 
expression - it has been well documented that activation 
of protein kinase(s) C represent a necessary signal trans- 
ducing step [16]. The requirements for its activation, how- 
ever, appear to be entirely different. We and others have 
shown recently that a rapid and transient activation, which 
can experimentally be induced by the addition of short-lived 
membrane permeable diacylglycerols in the presence of 
Ca*‘-raising ionophores, is sufficient for inducing the 
synthesis of the IL-2 receptors [3-6,16,17], whereas under 
such conditions no IL-2 synthesis can be observed. 
In contrast, repetitive addition of diacylglycerols or of 
the slowly metabolized phorbol ester (PMA) also induce 
the synthesis of this cytokine ([3,4,18]; see also Fig. 1 and 
Table 1). From these experiments it has been postulated 
that IL-2 synthesis requires the maintenance of protein 
kinase C activation for a sustained period of time [16]. 
Indeed, PMA alone or in combination with the calcium 
ionophore, ionomycin, have been shown to evoke pro- 
longed activation and translocation of protein kinase(s) C 
([5,16]; see also Table 3). Under these conditions both 
classical (cPKC) and calcium independent (nPKC) iso- 
types of PKC are activated and translocated [19]. The lack 
of effect of ouabain (even at concentrations as high as 1 
PM) implicates that the glycoside does not interfere with 
direct activation of any of the ‘classical’ or calcium-inde- 
pendent isoenzymes of PKC. 
We have shown earlier that BMA 031, as well as other 
antibodies binding to the T-cell antigen receptor/CD3 
complex and able to trigger human peripheral T-lympho- 
cytes to proliferate, lead to a bimodal activation of protein 
kinase C. A rapid and transient translocation is followed 
by a second phase of activation which is maintained for at 
least several hours ([5,6] and Fig. 2). 
More specifically, as shown in this paper, activation via 
the T-cell antigen receptor led within 5 min to a transient 
translocation of protein kinase C-a to the plasma mem- 
branes, followed by a fast dissociation as shown by im- 
munoblot analysis (Fig. 3). After 90 min of stimulation 
protein kinase C-p was translocated and remained bound 
to the plasma membranes for up to 4 h (Fig. 3). Incubation 
of cells with 50 nM ouabain did not influence translocation 
of protein kinase C-cr. In contrast, the sustained activation 
of protein kinase C-j3 was specifically and completely 
abolished by ouabain. 
Our results thus suggest, that activation of protein ki- 
nase C-a, a ouabain insensitive step of signal transduction, 
might be responsible for the regulation of IL-2 receptor 
expression. On the other hand, inhibition of the transloca- 
tion and activation of protein kinase C-p also abolished 
IL-2 synthesis, suggesting that sustained activation of this 
protein kinase C isotype is involved in the regulation of 
IL-2 gene expression and synthesis in human lymphocytes. 
The finding that concentrations of 50 nM ouabain do 
not inhibit IL-2 synthesis when protein kinase(s) C is 
directly activated by the combination of PMA and iono- 
mycin suggests that ouabain interferes with processes 
proximal to the activation of protein kinase C, i.e., with 
signal transduction pathways associated with its activation. 
Triggering of the T-cell antigen receptor/CD3 complex is 
associated with an activation of phospholipase C-y, lead- 
ing to a breakdown of phosphatidylinositolbisphosphate 
(PIP,) within the first minutes of activation [20]. Although 
not formally proven, the close temporal correlation sug- 
gests that the initial transient activation of protein kinase 
C-cr may be related to the ‘PI response’ and thus to 
generation of diacylglycerols from PIP, and elevation of 
intracellular calcium by inositoltriphosphate, IP,. Ouabain 
did not affect this pathway, as evident from an unchanged 
rise in the cytosolic calcium concentration in BMA 031 
stimulated lymphocytes (see Fig. 4). 
The physiologically formed diacylglycerols have re- 
cently been shown to have half lives of less than 10 min 
[21]. The T-cell antigen receptor/CD3 complex associated 
transient activation of phospholipase C-y thus cannot ex- 
plain the sustained activation of protein kinase C-p. Data 
of several laboratories indicated that the T-cell antigen 
receptor/CD3 complex regulates IL-2 synthesis by its 
ability to regulate multiple intracellular signals in T cells 
[16,21,22]. The involvement of a phospholipase C-y inde- 
pendent signalling pathway for IL-2 synthesis has been 
evoked recently by Wegener et al. [23]. They suggested 
that the T-cell antigen receptor/CD3 complex contains at 
least two parallel transduction modules [23]. Recently we 
have shown that incorporation of polyunsaturated fatty 
acids into plasma membrane phospholipids might be in- 
volved in the prolonged activation of protein kinase C [6]. 
In animal T-lymphocytes mitogen stimulation leads to a 
rapid preferential incorporation of polyunsaturated fatty 
acids, and thus to an increase of their content in phospho- 
lipids [ 13,241. Ouabain at concentrations, which inhibited 
mitogen induced proliferation, also prevented incorpora- 
tion of polyunsaturated fatty acids in rabbit lymphocytes 
by inhibiting the activation of the key enzyme acyl 
CoA:lysophosphatide acyltransferase [13]. We show here 
that BMA 031, too, leads to an increased incorporation of 
polyunsaturated fatty acids into phospholipids of human 
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lymphocytes; 50 nM ouabalin was sufficient to completely 
inhibit BMA 031-induced increase in fatty acid incorpora- 
tion (Fig. 5). As the same concentrations of the cardiac 
glycoside also prevented prolonged activation of protein 
kinase C-p (and subsequent IL-2 synthesis), it suggests 
that plasma membrane phospholipid fatty acid metabolism 
is associated with T-cell antigen receptor-dependent sig- 
nalling pathways associated with the prolonged activation 
of this protein kinase C isoenzyme. A plausible molecular 
mechanism could consist in the generation of diacylglyc- 
erols from phosphatidylcholine by a phosphatidylcholine 
specific phospholipase C/D. Phosphatidylcholine in T- 
lymphocytes contains predominantly saturated fatty acids 
124,251. Diacylglycerols which are able to activate protein 
kinase C must, however, contain polyunsaturated fatty 
acids [26]. Increased incorporation of polyunsaturated fatty 
acids into phosphatidylcholine thus may be a prerequisite 
for generating protein kinase C activating diacylglycerols 
via this pathway. We have recently found a calcium-de- 
pendent plasma membrane bound phospholipase D in the 
plasma membranes of human lymphocytes, resulting in 
elevated diacylglycerol levels upon stimulation (H. Leuf- 
gen, K. Resch and M. Szamel, unpulblished data). 
In previous studies we have shown that the cell surface 
receptor of ouabain, e.g., Na+/K+-ATPase and lysophos- 
phatide acyltransferase were spatially and functionally cou- 
pled with the high affiniiy ‘mitogen receptors’ in calf, 
rabbit, and human lymphocytes [27-291. More recently by 
the means of affinity chromatography on immobilized 
anti-CD3 monoclonal antibmodies we succeeded in isolating 
plasma membrane subfractions from human Jurkat T-cells; 
in plasma membrane vesicles bearing the T-cell antigen 
receptor/CD3 complex high specific activity of (Na+ + 
K+)ATPase and lysophosphatide acyltransferase was de- 
tected, suggesting an association of both enzymes with the 
T-cell antigen receptor/CD3 complex (M. Szamel and K. 
Resch, unpublished data). 
The results suggest that the two essential events in 
T-lymphocytes activation, the synthesis of IL-2 and the 
expression of its cell surface receptors require different 
activation signals. While the IL-2 receptor gene expression 
might be regulated by the activation of protein kinase C-a, 
IL-2 synthesis and cellular proliferation require sustained 
activation of protein kinase C-/3. 
We thus propose that the T-cell antigen receptor/CD3 
complex is coupled to phospholipase C-y, as well as to 
enzymes of the deacylation-reacylation cycle, phospho- 
lipase A, and lysophosphaltide acyltransferase, both being 
essential for T-lymphocyte activation [4,5,16]. Activation 
of receptor-coupled lysophosphatide acyltransferase and 
thus the incorporation of c&polyunsaturated fatty acids 
into plasma membrane phcspholipids leads to a prolonged 
activation of protein kinase C-/3 and thus to IL-2 gene 
expression and clonal expansion of T-lymphocytes. 
The inhibition of the activation of human lymphocytes 
by ouabain bears similarities to the mechanism of immuno- 
suppression by cyclosporin A. Cyclosporin A too inhibits 
IL-2 synthesis without affecting IL-2 receptor expression 
[30]. Recently we found that in human peripheral lympho- 
cytes - as used in this study - cyclosporin A also sup- 
pressed activation of protein kinase C-p selectively with- 
out affecting activation of protein kinase C-cr, which be- 
sides the inhibition of the calcineurin phosphatase might 
represent a novel target for the immunosuppressive agent 
[311. 
Taken together the results suggest that the two key 
events in the mitogenic activation of T-lymphocytes, the 
synthesis of IL-2 and the expression of its surface recep- 
tors involve different signalling pathways which both orig- 
inate from the T-cell antigen receptor/CD3 complex. Ex- 
pression of high affinity receptors for IL-2 is dependent on 
the transient activation of protein kinase C-a, which is 
mediated by the activation of phosphatidylinositol-bisphos- 
phate specific phospholipase C--y. Gene expression of IL-2 
requires the sustained activation of protein kinase C-p, 
which is independent of the activation of phospholipase 
C-y. The signal transduction leading to the activation of 
protein kinase C-p is less clear, but appears to involve 
changes of the fatty acid moieties of plasma membrane 
phospholipids. 
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